Cisplatin neurotoxicity
New England Journal of Medicine 323(1): 64-65
1990
ISSN/ISBN: 0028-4793 PMID: 2355961 Document Number: 362422
Document emailed within 1 workday
Related Documents
Kobayashi, H. 1985: Cisplatin and ovarian carcinoma--early detection of cisplatin-induced nephrotoxicity Nihon Sanka Fujinka Gakkai Zasshi 37(6): 888-896Makhnova, E.V. 2003: Combination chemotherapy with Hemzar (gemcitabine) and cisplatin for relapsing and cisplatin-resistant ovarian cancer Voprosy Onkologii 49(1): 60-65
Zhao, J. 1985: Cisplatin or combined cisplatin and 60Co radiation in the treatment of advanced lung cancer--report of 145 cases Zhonghua Zhong Liu Za Zhi 7(4): 283-285
Kudoh, K.; Kita, T.; Hirata, J.; Ishii, K.; Hiramatsu, H.; Kikuchi, Y.; Nagata, I. 1994: Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine Nihon Sanka Fujinka Gakkai Zasshi 46(6): 525-532
González-Larriba, J.L.; Garcia Carbonero, I.; Sastre Valera, J.; Perez Segura, P.; Diaz-Rubio, E. 1997: Neoadjuvant therapy with cisplatin/fluorouracil vs cisplatin/UFT in locally advanced squamous cell head and neck cancer Oncology 11(9 Suppl 10: 90-97
Yu, Y.; Zhang, X.; Tian, H.; Zhang, Z.; Tian, Y. 2018: Knockdown of long non-coding RNA HOTAIR increases cisplatin sensitivity in ovarian cancer by inhibiting cisplatin-induced autophagy Journal of BUON: Official Journal of the Balkan Union of Oncology 23(5): 1396-1401
Johnson, S.W.; Swiggard, P.A.; Handel, L.M.; Brennan, J.M.; Godwin, A.K.; Ozols, R.F.; Hamilton, T.C. 1994: Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells Cancer Research 54(22): 5911-5916
Sukhaboon, J.; Porapakkhan, P.; Penpattanagul, S. 2009: Randomized comparison of fluorouracil plus cisplatin vs. cisplatin as an adjunct to radiation therapy in stage IIB-IVA squamous cell carcinoma of the cervix: pilot study Journal of the Medical Association of Thailand 92(8): 1072-1076
Zhang, M-Chun.; Hu, C-Ping.; Chen, Q. 2006: Effect of down-regulation of survivin gene on apoptosis and cisplatin resistance in cisplatin resistant human lung adenocarcinoma A549/CDDP cells Zhonghua Zhong Liu Za Zhi 28(6): 408-412
Fichtinger-Schepman, A.M.; Vendrik, C.P.; van Dijk-Knijnenburg, W.C.; de Jong, W.H.; van der Minnen, A.C.; Claessen, A.M.; van der Velde-Visser, S.D.; de Groot, G.; Wubs, K.L.; Steerenberg, P.A. 1989: Platinum concentrations and DNA adduct levels in tumors and organs of cisplatin-treated LOU/M rats inoculated with cisplatin-sensitive or -resistant immunoglobulin M immunocytoma Cancer Research 49(11): 2862-2867
West, R.J.; Zweig, S.F. 1997: Meta-analysis of chemotherapy regimens for ovarian carcinoma: a reassessment of cisplatin, cyclophosphamide and doxorubicin versus cisplatin and cyclophosphamide European Journal of Gynaecological Oncology 18(5): 343-348
Pizzocaro, G.; Milani, A.; Piva, L.; Faustini, M.; Spino, E. 1991: Methotrexate, vinblastine, adriamycin and cisplatin versus methotrexate and cisplatin in advanced urothelial cancer. A randomized study European Urology 20(2): 89-92
Ema, M.; Fukui, Y.; Aoyama, H.; Fujiwara, M.; Fuji, J.; Inouye, M.; Iwase, T.; Kihara, T.; Oi, A.; Otani, H.; Shinomiya, M.; Sugioka, K.; Yamano, T.; Yamashita, K.H.; Tanimura, T. 2007: Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity Congenital anomalies 47(2): 74-76
Niiya, F.; Ikeda, S.; Nagata, S.; Iwamoto, M.; Shirouzu, K. 2001: A case of advanced gastric cancer complicated with liver metastases responding remarkably to combined chemotherapy with 5-fluorouracil and low-dose cisplatin, with UFT and low-dose cisplatin for maintenance on an outpatient basis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(3): 391-394
Barker, G.H.; Wiltshaw, E. 1981: Randomised trial comparing low-dose cisplatin and chlorambucil with low-dose cisplatin, chlorambucil, and doxorubicin in advanced ovarian carcinoma Lancet 1(8223): 747-750
Ishikawa, T.; Irie, G.; Asakawa, H.; Ikeda, M.; Dokiya, T.; Morita, K.; Inoue, T.; Masuda, K. 1990: Assessment of cisplatin in concurrent use with radiotherapy in esophageal carcinoma--joint research among nationwide multi-facilities, primary results. Research Committee for Radiation and Cisplatin Treatment of Esophageal Carcinoma Gan no Rinsho. Japan Journal of Cancer Clinics 36(1): 1-6
Aggarwal, P. 1994: INH-induced neurotoxicity Journal of the Association of Physicians of India 42(5): 429
Hutchinson, B.R. 2003: Lignocaine neurotoxicity New Zealand Medical Journal 116(1178): U525
Jortner, B.S.; Cho, E.S. 1981: Neurotoxicity of quelamycin in the rat Neurotoxicology 2(4): 789-792
Kopp, K.; Hansen, S.W. 1991: Neurotoxicity in chemotherapy Sygeplejersken 91(49): 4-8